“5am-ventures” Archives

in
Entry Author Date Location
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Scientist.com Raises $24M for “Pharma Markets” that Outsource R&D 05/15/17 San Diego
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
scPharmaceuticals Obtains $45,600,000 Series B Financing Round 01/05/17 Boston
Impel NeuroPharma Receives $36,000,000 Series C Financing Round 12/06/16 Seattle
Nohla Therapeutics Garners $43,500,000 Series A Financing 12/01/16 Seattle
Chrono Therapeutics Scores $47.6M to Advance Anti-Smoking System 09/09/16 San Francisco
Chrono Therapeutics Secures $47,600,000 Series B Financing Round 09/09/16 San Francisco
Cleave Biosciences Receives $37,000,000 Series B Financing 08/09/16 San Francisco
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Bioz, Using Machine Learning to Optimize Biology, Launches With $3M 07/20/16 San Francisco
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Purigen Biosystems Lands $18,200,000 Series A Funding Round 05/18/16 San Francisco
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
IDEAYA Biosciences Secures $46,000,000 Series A Funding Round 05/05/16 San Francisco
Homology Medicines Obtains $43,500,000 Series A Round 05/03/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
Bird Rock Bio Nears Pivotal Trial of New Biologic Drug for RA 03/16/16 San Diego
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Pear Therapeutics Garners $20,000,000 New Financing 02/03/16 San Francisco
Biodesy Receives $10,000,000 Series B Round 01/25/16 San Francisco
Millendo Therapeutics Receives $62,000,000 Series B Funding 01/04/16 Detroit Ann Arbor
Crinetics Pharmaceuticals Lands $40,000,000 Series A Financing Round 11/03/15 San Diego
Crinetics Pharma Raises $40M in Comeback for Ex-Neurocrine Bio Team 11/02/15 San Diego
Arvinas Obtains $41,600,000 Series B Funding 10/21/15 Boston
Portal Instruments Secures $25,000,000 Series B Financing Round 10/20/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
Page 1 of 5 next page »